SLC29A2 and acute myeloid leukemia: This analysis would provide valuable insights into the biological significance and functional implications of the selected genes, mainly MICALL2, KIAA0141, and SLC29A2, potentially revealing novel biomarkers or therapeutic targets related to AML.